 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Invitrogen Corporation
 |
Invitrogen Corporation |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Invitrogen operating income beats forecasts Jul 26 2001 01:25 PM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
IPO Weekly: Checking in With the Hardy Few IPO Funds
Mar 30 2001 03:46 PM PST
PROFILE |
 |
Looking to make a quick clone? Invitrogen can help. The company makes kits that simplify and speed up gene cloning, expression, and analysis for corporate, academic, and government research. One of its products, the TOPO TA Cloning Kit, reduces a step in the cloning process from 12 hours to just five minutes. Its Echo Cloning System speeds the process of cloning gene targets into multiple gene expressions. The firm offers about 700 kits and other products to clients in Europe, North America, and Asia. Invitrogen has manufacturing facilities in California, Germany, and the Netherlands.
COMPETITION |
 |
Affymetrix, Inc. (AFFX)
Applied Biosystems Group (ABI)
Clontech Laboratories, Inc. (dossier)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 246.20
1-Yr. Sales Growth: 260.5%
Employees: 2,981
Revenue per employee: $82,589.73
KEY PEOPLE |
 |
Lyle C. Turner
CEO
James R. Glynn
CFO
CONTACT INFO |
 |
1600 Faraday Ave.
Carlsbad, CA 92008
US
Phone: 760-603-7200
Fax: 760-603-7201
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |